National Association of Manufacturers (NAM)
FDANonrulemakingFDA-2018-N-3240

List of Bulk Drug Substances For Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Notice

RIN
Last modified
Jun 26, 2026
Comment window
closes in 2d
National Association of Manufacturers (NAM) filings
1

Activity

National Association of Manufacturers (NAM) filed 1 comment on this docket between Jul 24, 2026 and Jul 24, 2026. 28 other organizations filed here. The comment window closes in 2d.

What National Association of Manufacturers (NAM) filed (1)

Jul 24, 2026· Comment from National Association of Manufacturers· FDA-2018-N-3240-3318

The National Association of Manufacturers (NAM) appreciates the opportunity to submit the attached comments in response to FDA's evaluation of "List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act".

Abstract

No abstract recorded.

View on regulations.gov →